Brad Mathis Email & Phone Number

Bel Air, MD, US

Mechanical Tissue Resuscitation™ (MTR™) is a revolutionary, transformative technology to actively remove excess fluids in damaged tissues of the brain, heart and spine to help mitigate the effects of secondary injury. With the use of a controlled application of sub-atmospheric pressure in the treatment of injuries, MTR™ offers a new therapeutic modality in.

At Entropy Bio, we are dedicated to discovering and developing the most impactful and advanced therapeutics for rare disease and cancer by seeking the root cause of disease, exploiting the recent explosion of biological knowledge, and fueling experienced teams with predictive platforms and infrastructure to innovate.

Boston, MA, US

London, United Kingdom, GB

Orchard Therapeutics is a clinical stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies. Our vision is to become the leader in gene therapy for primary immune deficiencies and inherited metabolic disorders.

Developed successful commercialization and launch plans for VTS-270 for NPC, a lysosomal storage disorder. Led on-going build-out and management of US customer-facing functions. Developed and executed strategic sales plan as well as hired and established US commercial field positions within sales, marketing, market access, diagnostics, and clinical thought.

Boston, Massachusetts, US

Managed team of six regional directors and 42 regional managers to achieve and exceed sales targets for complement franchise calling on hematologists, nephrologists, hospitalists, hematopathologists, and intensivists for indications of PNH and aHUS. Collaborated closely with US marketing teams to impact marketing plans. Drove US marketing plan through key.

Boston, Massachusetts, US

Developed, implemented and influenced collaborative to ensure access to Soliris (Eculizumab) for ultra-orphan population of patients with PNH, aHUS and Asfotase Alfa for HPP. Created and led top-performing national team executing ultra-orphan business strategy with regards to payers, PBMs and SPP for all approved indications. Aligned business strategy and.

Boston, Massachusetts, US

Managed team of directors, associate directors and senior managers to execute strategic objectives for market development, indication growth and patient retention strategy. Focused brand strategy on digital, non-personal, patient(DTC) and HCP Nephrology Specialty. Managed $12,500,000 budget. Oversaw situational assessment development, strategic plan.

Boston, Massachusetts, US

Oversaw training department. Managed global infrastructure for training and development across 50 countries, supporting clinical training for Soliris in PNH and aHUS. Served as global trainer. Built and executed comprehensive module system to standardized training curriculum. Led through continuum from development to implementation of sales training.

Boston, Massachusetts, US

Led team of eight regional account managers covering central US from Texas to Michigan for launch of first indication in hematology. Managed team to achieve corporate objectives to identify new patients, create access, and support appropriate utilization. Oversaw strategic planning and execution of sales plans. Established appropriate relationships with.

Lawrence Township, NJ, US

Responsibilities included hiring the initial sales team for the launch of Orencia, a biologic for RA. Position reported to the Vice President of Sales, Southwest Region.

Cambridge, MA, US

Regional Sales Manager for a team of Sales Representatives selling a biologic for Psoriasis. The product was sold off in 2005.

Bba, Economics

Bachelor'S Degree, Economics